Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how pegylated phosphotidylethanolamine (PEG-PE) nanotechnology inhibits P-glycoprotein expression and enhances chemotherapy drug retention in resistant cancer cells.